by admin | Dec 12, 2016 | Stem Cell News
Share ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (NYSE MKT: BTX), a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today announced that Co-Chief Executive Officer Michael D. West, Ph.D.,...
by admin | Dec 10, 2016 | Stem Cell News
LOS ANGELES, Dec. 9, 2016 /PRNewswire-USNewswire/ — Today, March of Dimes, the leading non-profit organization for pregnancy and baby health, raised $1.4 million at the sixth annual March of Dimes Celebration of Babies: A Hollywood Luncheon , which took at the...
by admin | Dec 9, 2016 | Stem Cell News
It’s generally thought that women are born with a finite number of egg cells, and cannot grow new ones. But in a new study, researchers got a surprise when they found that women undergoing a particular chemotherapy had a much greater number of eggs in their...
by admin | Dec 8, 2016 | Stem Cell News
19,587.00 23.00 (0.12%) BioTime Co-CEO Dr. Michael D. West to Deliver Plenary Presentation on the Field of Induced Tissue Regeneration at World Stem Cell Summit Share ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (NYSE MKT: BTX), a clinical-stage...
by admin | Dec 7, 2016 | Stem Cell News
Tip : Use comma (,) to separate multiple quotes. Learn more… Wed, Dec 7, 2016, 12:36 GMT – UK Markets close in 3 hrs 54 mins New governance at CellProthera MULHOUSE, France–(BUSINESSWIRE)– Matthieu de Kalbermatten nominated as CEO CellProthera,...
by admin | Dec 7, 2016 | Stem Cell News
NEW BRUNSWICK, N.J., Dec. 6, 2016 /PRNewswire-USNewswire/ — Visikol Inc., originally funded with an investment from Foundation Venture Capital Group, has launched Visikol ® HISTO™ , the market’s first portfolio of tissue clearing kits and reagents that can...
